Tjoapack and Veratrak launch EPOCH initiative
![](/46/pdcnewsitem/07/51/19/BM4A3980.jpg)
The virtual platform is designed to allow the healthcare industry to effectively research and explore new technologies that will help to shape the future of the pharmaceutical supply chain.
Global contract packaging and supply chain organisation (CPO), Tjoapack and UK-based technology company, Veratrak, have launched the European Platform on Changing Healthcare (EPOCH) as part of their ongoing partnership dedicated to improving pharmaceutical supply chain operations.
EPOCH is a virtual platform which is designed to allow the healthcare industry to effectively research and explore new technologies that will help to shape the future of the pharmaceutical supply chain and improve patient care.
The new platform will focus on a different theme every 6 months. The first theme will be blockchain, in line with the project Tjoapack and Veratrak are currently working on to secure and optimise the data sharing processes involved in setting up stock keeping units (SKUs) ready for packaging.
Dr Anita Paz, Innovation Consultant, Tjoapack said: “We’re delighted to announce the launch of EPOCH. The platform will provide a collaborative environment for all its members and sponsors to facilitate the development of new ideas that will benefit the pharmaceutical supply chain.
“Beyond this, it will act as a communication tool to help proactively roll out these new ideas and provide an educational platform offering insight into new developments across the supply chain and how these can be best implemented. It’s an exciting project to be part of.
“At Tjoapack, we have a long history of employing innovative new technology to improve the pharmaceutical supply chain and we’re looking forward to seeing what we can achieve with Veratrak and the EPOCH member community.”
As well as providing a communication hub for the pharmaceutical and technology companies across the industry, the EPOCH platform will also produce original research intended to guide the application of new technologies within member supply chains.
Jason Lacombe, CEO, Veratrak said: “The EPOCH platform is the latest initiative to come out of our ongoing collaboration with Tjoapack. We’re committed to involving as many people as possible from the pharmaceutical supply chain in future projects so that we can pool our knowledge and resource for the benefit of the industry and ultimately the patients it serves.”
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance